ERBB2 and cancer: Another HER2-specific peptide (APTHER2) was conjugated with super-paramagnetic nanoparticles (SPION) and injected in HER2-positive tumor-bearing mice, in which it accumulated in the tumor mass, proving the in vivo binding ability to cancer cells [121].